专利号:US-7230101-B1 优先权日:2002-08-28 标 题:Synthesis of methotrexate-containing heterodimeric molecules 发明人:MURTHI KRISHNA K; SMITH CHASE C 权利人:GPC BIOTECH INC 摘要:The present invention relates to novel compositions of methotrexate-containing heterodimeric probe molecules, also known as chemical inducers of dimerization (CID), useful in three-hybrid assays. The invention further relates to synthesis of said compositions and their intermediates. Another aspect of the invention is a method for using the heterodimeric probe molecules described herein in drug screens to identify potential protein targets to a given ligand, optimize protein-ligand interactions, or identify potential ligands for a given protein target. In certain embodiments, the invention contemplates the synthesis of the following methotrexate-containing heterodimeric probe:
专利号:US-11542269-B2 优先权日:2018-01-03 标 题:Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof 发明人:CHOI HYEONG-WOOK; FANG FRANCIS G 权利人:EISAI R&D MAN CO LTD 摘要:The invention provides methods utilizing Prins reaction in the preparation of compounds that may be useful as intermediates in the synthesis of halichondrin macrolides and analogs thereof. The invention also provides compounds that may be useful as intermediates in the synthesis of a halichondrin macrolides and methods for preparing the same.
专利号:US-10913749-B2 优先权日:2015-05-07 标 题 :Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides 发明人:FANG FRANCIS G; KIM DAE-SHIK; CHOI HYEONG-WOOK; CHASE CHARLES E 权利人:EISAI R&D MAN CO LTD 摘要:The invention provides methods for the synthesis of a halichondrin macrolides through a macrocyclization strategy. The macrocyclization strategy of the present invention involves subjecting a non-macrocyclic intermediate to a carbon-carbon bond-forming reaction (e.g., an olefination reaction (e.g., Horner-Wadsworth-Emmons olefination), catalytic Ring-Closing Olefin Metathesis, or Nozaki-Hiyama-Kishi reaction) to afford a macrocyclic macrolide. The invention also provides compounds useful as intermediates in the synthesis of a halichondrin macrolides and methods for preparing the same.
专利号:US-11136335-B2 优先权日:2016-06-30 标题:Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof 发明人:CHASE CHARLES E; CHOI HYEONG-WOOK; ENDO ATSUSHI; FANG FRANCIS G; KIM DAE-SHIK 权利人:EISAI R&D MAN CO LTD 摘要:The invention provides methods for the synthesis of a halichondrin macrolides or analogs thereof through a cyclization reaction strategy. The strategy of the present invention involves subjecting an intermediate to Prins reaction conditions to afford a macrolide. The invention also provides compounds useful as intermediates in the synthesis of a halichondrin macrolides or analogs thereof and methods for preparing the same.
专利号:US-2004249114-A1 优先权日:2001-02-06 标题 :Methods of synthesis of polysuccinimide or polyaspartate by end capping polymerization 发明人:SWIFT GRAHAM; REDLICH GEORGE H; WEHBY JOHN NOLAN 摘要:Disclosed are methods of synthesis of homopolymers or copolymers containing succinimide or aspartate moieties formed in the presence of an end capping initiator. Also disclosed are methods of isolating, compounding, stabilizing and processing the homopolymers and copolymers.
专利号:US-2006211843-A1 优先权日:2001-02-06 标题:Methods of synthesis of poly(succinimide-aspartate) polysuccinimide or polyaspartate by end capping polymerization 发明人:SWIFT GRAHAM; REDLICH GEORGE H 权利人:SWIFT GRAHAM; REDLICH GEORGE H 摘要:Disclosed are methods of synthesis of homopolymers or copolymers containing succinimide or aspartate moieties formed in the presence of an end capping initiator. Also disclosed are methods of isolating, compounding, stabilizing and processing the homopolymers and copolymers.
[参考文献]: Cai-Yun Geng, Et Al. Theoretical Elucidation Of The Rhodium-Catalyzed [参考文献]: Chuanjin Tian, Et Al. Enantiomerization Mechanism Of Thalidomide And The Role Of Water And Hydroxide Ions. Chemistry. 2012 Nov 5;18(45):14305-13. [参考文献]: Jeong-Woo Seo, Et Al. Comparative Characterization Of The Lactimidomycin And Iso-Migrastatin Biosynthetic Machineries Revealing Unusual Features For Acyltransferase-Less Type I Polyketide Synthases And Providing An Opportunity To Engineer New Analogues. Biochemistry. 2014 Dec 16;53(49):7854-65. [参考文献]: Jianhua Ju, Et Al. Evaluation Of New Migrastatin And Dorrigocin Congeners Unveils Cell Migration Inhibitors With Dramatically Improved Potency. Bioorg Med Chem Lett. 2008 Nov 15;18(22):5951-4. [参考文献]: Jianhua Ju, Et Al. Iso-Migrastatin Congeners From Streptomyces Platensis And Generation Of A Glutarimide Polyketide Library Featuring The Dorrigocin, Lactimidomycin, Migrastatin, And Nk30424 Scaffolds. J Am Chem Soc. 2005 Aug 31;127(34):11930-1.
合成参考文献
摘要:Archives Internationales de Pharmacodynamie et de Therapie., 173(115), 1968 [] 摘要:Tang, R.-Y., Science of Synthesis: Knowledge Updates, (2024) 1, 339. 参考文献:10.1080/10286020500382884 摘要:Cheng C, Liu Q, Chen L, Jin W, Si S, Li D. Isolation, structure determination and biological activity of a new glutarimide antibiotic, S632A3. Journal of Asian Natural Products Research. 2006 Jan;8(1-2):55–60. doi: 10.1080/10286020500382884. 参考文献:10.1093/jxb/erp350 摘要:Sadok W, Sinclair TR. Transpiration response of 'slow-wilting' and commercial soybean (Glycine max (L.) Merr.) genotypes to three aquaporin inhibitors. J Exp Bot. 2010 Mar;61(3):821–9. 参考文献:10.1021/acs.jmedchem.9b00454 摘要:Heim C, Pliatsika D, Mousavizadeh F, Bär K, Hernandez Alvarez B, Giannis A, Hartmann MD. De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives. J. Med. Chem. 2019 Jun 28;62(14):6615–29. doi: 10.1021/acs.jmedchem.9b00454.